Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
GLP-1 medications slow down the movement of the intestinal tract
If approved, orforglipron may offer a convenient alternative to injectable therapies that supports early intervention and long-term disease management, helping to meet the preference of millions who favor oral medications. Global submissions for the treatment of obesity or overweight are planned by the end of 2025, with diabetes submissions to follow in 2026
It carries enough volume to reconstitute several peptide vials at standard dosing concentrations while still being small enough to fully consume well inside the 28-day preservative window
Supplied in a 30mL multi-dose vial, it is intended for research and laboratory use only, commonly used for the reconstitution of lyophilized peptides and other non-clinical compounds under controlled conditions
Lawsuits and allegations MEDVi reported 250,000 customers by the end of 2025, with the Times quoting Gallaghers description of the growth as insane and accelerating
